Literature DB >> 18321170

Lipid-lowering medication use and aggression scores in women: a report from the NHLBI-sponsored WISE study.

Marian B Olson1, Sheryl F Kelsey, Karen A Matthews, C Noel Bairey Merz, Wafia Eteiba, Susan P McGorray, Carol E Cornell, Diane A Vido, Matthew F Muldoon.   

Abstract

AIM: The aim of this study was to examine the association between the use of lipid-lowering medication and aggressive responding, hostility, cynicism, and depression scores in women undergoing coronary angiography.
METHODS: The cohort included 498 women from the National Heart, Lung and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. WISE is a four-center study of women with chest pain who underwent quantitative coronary angiography for suspected myocardial ischemia. The psychosocial indices included the Cook Medley Hostility questionnaire, measuring aggression, hostility, and cynicism, and the Beck Depression Inventory (BDI).
RESULTS: Compared to those not on lipid-lowering medication, women receiving lipid-lowering pharmacotherapy were older (62 vs. 55 years, p < 0.001) and had more hypertension, dyslipidemia, diabetes, and coronary artery disease (CAD, defined as > or =50% stenoses in at least one epicardial artery) (all p < 0.003). Women on lipid-lowering medication had higher aggressive responding scores than those not on medication, 3.0 +/- 1.8 vs. 2.7 +/- 1.7, respectively (age-adjusted p < 0.003). This association persisted after adjustment for coronary risk factors, education, and extent of angiographic disease (CAD) (p < 0.005), and after exclusion of women using psychotropic medications (p < 0.001). Hostility, cynicism, and depression scores did not differ by medication use.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18321170      PMCID: PMC2896287          DOI: 10.1089/jwh.2007.0379

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  53 in total

1.  Low serum cholesterol concentration and risk of suicide.

Authors:  L F Ellison; H I Morrison
Journal:  Epidemiology       Date:  2001-03       Impact factor: 4.822

2.  Total serum cholesterol in relation to psychological correlates in parasuicide.

Authors:  M Garland; D Hickey; A Corvin; J Golden; P Fitzpatrick; S Cunningham; N Walsh
Journal:  Br J Psychiatry       Date:  2000-07       Impact factor: 9.319

3.  Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory).

Authors:  B L Sharaf; C J Pepine; R A Kerensky; S E Reis; N Reichek; W J Rogers; G Sopko; S F Kelsey; R Holubkov; M Olson; N J Miele; D O Williams; C N Merz
Journal:  Am J Cardiol       Date:  2001-04-15       Impact factor: 2.778

4.  Low cholesterol and violent crime.

Authors:  B A Golomb; H Stattin; S Mednick
Journal:  J Psychiatr Res       Date:  2000 Jul-Oct       Impact factor: 4.791

5.  Psychosocial variables are associated with atherosclerosis risk factors among women with chest pain: the WISE study.

Authors:  T Rutledge; S E Reis; M Olson; J Owens; S F Kelsey; C J Pepine; N Reichek; W J Rogers; C N Merz; G Sopko; C E Cornell; K A Matthews
Journal:  Psychosom Med       Date:  2001 Mar-Apr       Impact factor: 4.312

6.  Serum cholesterol concentrations and mood states in violent psychiatric patients: an experience sampling study.

Authors:  M Hillbrand; B M Waite; D S Miller; R T Spitz; V M Lingswiler
Journal:  J Behav Med       Date:  2000-12

Review 7.  Cholesterol metabolism in the brain.

Authors:  J M Dietschy; S D Turley
Journal:  Curr Opin Lipidol       Date:  2001-04       Impact factor: 4.776

8.  Cholesterol reduction and non-illness mortality: meta-analysis of randomised clinical trials.

Authors:  M F Muldoon; S B Manuck; A B Mendelsohn; J R Kaplan; S H Belle
Journal:  BMJ       Date:  2001-01-06

9.  Simvastatin causes changes in affective processes in elderly volunteers.

Authors:  Knashawn Morales; Marsha Wittink; Catherine Datto; Suzanne DiFilippo; Mark Cary; Thomas TenHave; Ira R Katz
Journal:  J Am Geriatr Soc       Date:  2006-01       Impact factor: 5.562

10.  Lovastatin induces apoptosis of spontaneously immortalized rat brain neuroblasts: involvement of nonsterol isoprenoid biosynthesis inhibition.

Authors:  N García-Román; A M Alvarez; M J Toro; A Montes; M J Lorenzo
Journal:  Mol Cell Neurosci       Date:  2001-02       Impact factor: 4.314

View more
  14 in total

1.  Candidate SNP markers of aggressiveness-related complications and comorbidities of genetic diseases are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters.

Authors:  Irina V Chadaeva; Mikhail P Ponomarenko; Dmitry A Rasskazov; Ekaterina B Sharypova; Elena V Kashina; Marina Yu Matveeva; Tatjana V Arshinova; Petr M Ponomarenko; Olga V Arkova; Natalia P Bondar; Ludmila K Savinkova; Nikolay A Kolchanov
Journal:  BMC Genomics       Date:  2016-12-28       Impact factor: 3.969

2.  Sex-Related Disparities in Criminal Justice and HIV Treatment Outcomes: A Retrospective Cohort Study of HIV-Infected Inmates.

Authors:  Jaimie P Meyer; Javier Cepeda; Faye S Taxman; Frederick L Altice
Journal:  Am J Public Health       Date:  2015-07-16       Impact factor: 9.308

3.  First-degree relatives with behavioural adverse effects on statins.

Authors:  David Reilly; Stephanie Cham; Beatrice Alexandra Golomb
Journal:  BMJ Case Rep       Date:  2011-10-28

Review 4.  Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.

Authors:  Marco Tuccori; Sabrina Montagnani; Stefania Mantarro; Alice Capogrosso-Sansone; Elisa Ruggiero; Alessandra Saporiti; Luca Antonioli; Matteo Fornai; Corrado Blandizzi
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

Review 5.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

6.  Statin Effects on Aggression: Results from the UCSD Statin Study, a Randomized Control Trial.

Authors:  Beatrice A Golomb; Joel E Dimsdale; Hayley J Koslik; Marcella A Evans; Xun Lu; Steven Rossi; Paul J Mills; Halbert L White; Michael H Criqui
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

7.  Revisiting the J shaped curve, exploring the association between cardiovascular risk factors and concurrent depressive symptoms in patients with cardiometabolic disease: Findings from a large cross-sectional study.

Authors:  Bhautesh Dinesh Jani; Jonathan Cavanagh; Sarah J E Barry; Geoff Der; Naveed Sattar; Frances S Mair
Journal:  BMC Cardiovasc Disord       Date:  2014-10-28       Impact factor: 2.298

8.  Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.

Authors:  Maciej Banach; Manfredi Rizzo; Peter P Toth; Michel Farnier; Michael H Davidson; Khalid Al-Rasadi; Wilbert S Aronow; Vasilis Athyros; Dragan M Djuric; Marat V Ezhov; Robert S Greenfield; G Kees Hovingh; Karam Kostner; Corina Serban; Daniel Lighezan; Zlatko Fras; Patrick M Moriarty; Paul Muntner; Assen Goudev; Richard Ceska; Stephen J Nicholls; Marlena Broncel; Dragana Nikolic; Daniel Pella; Raman Puri; Jacek Rysz; Nathan D Wong; Laszlo Bajnok; Steven R Jones; Kausik K Ray; Dimitri P Mikhailidis
Journal:  Arch Med Sci       Date:  2015-03-14       Impact factor: 3.318

9.  Mood, Personality, and Behavior Changes During Treatment with Statins: A Case Series.

Authors:  Stephanie Cham; Hayley J Koslik; Beatrice A Golomb
Journal:  Drug Saf Case Rep       Date:  2016-12

Review 10.  The impact of statins on psychological wellbeing: a systematic review and meta-analysis.

Authors:  Adrienne O'Neil; Livia Sanna; Cassie Redlich; Kristy Sanderson; Felice Jacka; Lana J Williams; Julie A Pasco; Michael Berk
Journal:  BMC Med       Date:  2012-12-03       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.